Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Zurakowski, Ph.D.

Co-Author

This page shows the publications co-authored by David Zurakowski and Soumitro Pal.
Connection Strength

0.634
  1. Activation of c-Met in cancer cells mediates growth-promoting signals against oxidative stress through Nrf2-HO-1. Oncogenesis. 2019 Jan 15; 8(2):7.
    View in: PubMed
    Score: 0.207
  2. Honokiol inhibits c-Met-HO-1 tumor-promoting pathway and its cross-talk with calcineurin inhibitor-mediated renal cancer growth. Sci Rep. 2017 07 19; 7(1):5900.
    View in: PubMed
    Score: 0.186
  3. Effectiveness of a combination therapy using calcineurin inhibitor and mTOR inhibitor in preventing allograft rejection and post-transplantation renal cancer progression. Cancer Lett. 2012 Aug 28; 321(2):179-86.
    View in: PubMed
    Score: 0.128
  4. Altered VEGF mRNA stability following treatments with immunosuppressive agents: implications for cancer development. J Biol Chem. 2010 Aug 13; 285(33):25196-202.
    View in: PubMed
    Score: 0.114
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.